Suppr超能文献

美国私立保险女性中破伤风类毒素、白喉类毒素含量降低及无细胞百日咳疫苗接种率低的预测因素。

Predictors of Low Uptake of Prenatal Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Immunization in Privately Insured Women in the United States.

作者信息

Butler Anne M, Layton J Bradley, Li Dongmei, Hudgens Michael G, Boggess Kim A, McGrath Leah J, Weber David J, Becker-Dreps Sylvia

机构信息

Departments of Epidemiology, Biostatistics, Obstetrics & Gynecology, and Family Medicine and the Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, and RTI Health Solutions, Research Triangle Park, North Carolina.

出版信息

Obstet Gynecol. 2017 Apr;129(4):629-637. doi: 10.1097/AOG.0000000000001927.

Abstract

OBJECTIVE

To examine the uptake of prenatal tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) immunization among pregnant women in the United States.

METHODS

Using MarketScan data, we conducted a historical cohort study among pregnant women with employer-based commercial insurance in the United States who delivered between January 1, 2010, and December 31, 2014. We examined temporal trends of uptake, predictors of uptake, and timing of Tdap immunization.

RESULTS

Among 1,222,384 eligible pregnancies in 1,147,711 women, receipt of prenatal Tdap immunization increased from 0.0% of women who delivered in January 2010 to 9.8% who delivered in October 2012 (the date of the recommendation by the Advisory Committee on Immunization Practices for Tdap during every pregnancy) to 44.4% who delivered in December 2014. Among women who received Tdap during pregnancy, the majority were immunized between 27 weeks and 36 6/7 weeks of gestation per the Advisory Committee on Immunization Practices recommendation. In multivariable analyses among women who delivered between November 2012 and December 2014, rates of prenatal Tdap immunization were lower for women younger than 25 years of age (eg, 20-24 compared with 30-34 years rate ratio [RR] 0.83, 95% confidence interval [CI] 0.85-0.88), with other children (eg, three compared with zero children: RR 0.86, 95% CI 0.84-0.88), residing in the South compared with the Midwest (RR 0.81, 95% CI 0.80-0.82), or with emergency department visits in early pregnancy (RR 0.93, 95% CI 0.92-0.95). The proportion of pregnant women who received prenatal Tdap increased with increasing gestational age at birth.

CONCLUSION

By the end of 2014, fewer than half of pregnant women in the United States were receiving prenatal Tdap immunization. Implementation and dissemination strategies are needed to increase Tdap coverage among pregnant women, especially those who are young, have other children, or reside in the South.

摘要

目的

研究美国孕妇中破伤风类毒素、白喉类毒素减少量及无细胞百日咳(Tdap)疫苗的接种情况。

方法

利用市场扫描数据,我们对2010年1月1日至2014年12月31日期间在美国拥有雇主提供商业保险的孕妇进行了一项历史性队列研究。我们研究了接种情况的时间趋势、接种的预测因素以及Tdap疫苗接种的时间。

结果

在1,147,711名女性的1,222,384例符合条件的妊娠中,产前Tdap疫苗接种率从2010年1月分娩的女性中的0.0%增加到2012年10月分娩的女性中的9.8%(免疫实践咨询委员会建议每次妊娠接种Tdap的日期),再到2014年12月分娩的女性中的44.4%。在孕期接种Tdap的女性中,大多数按照免疫实践咨询委员会的建议在妊娠27周至36 6/7周之间接种。在2012年11月至2014年12月分娩的女性的多变量分析中,25岁以下的女性产前Tdap疫苗接种率较低(例如,20 - 24岁与30 - 34岁相比,率比[RR]为0.83,95%置信区间[CI]为0.85 - 0.88),有其他孩子(例如,有三个孩子与没有孩子相比:RR为0.86,95% CI为0.84 - 0.88),居住在南部与中西部相比(RR为0.81,95% CI为0.80 - 0.82),或在孕早期有急诊就诊(RR为0.93,95% CI为0.92 - 0.95)。接受产前Tdap疫苗接种的孕妇比例随着出生时孕周的增加而增加。

结论

到2014年底,美国不到一半的孕妇接受了产前Tdap疫苗接种。需要实施和推广策略来提高孕妇中Tdap疫苗的接种覆盖率,特别是那些年轻、有其他孩子或居住在南部的孕妇。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3202/5364044/247100633a85/nihms-842669-f0001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验